Saw Palmetto denial
This article was originally published in The Tan Sheet
Executive Summary
High court refuses petitioners who requested the court review FDA's denial of a health claim linking saw palmetto to benign prostatic hyperplasia, law firm Emord & Associates says Oct. 12. Julian Whitaker, et al., filed the writ of certiorari earlier this year (1"The Tan Sheet" Jan. 19, 2004, p. 16)...